115 related articles for article (PubMed ID: 20948218)
1. Intravenous tissue plasminogen activator thrombolysis in patients without major arterial occlusion seems to be safe and effective.
Kimura K; Iguchi Y; Shibazaki K; Sakamoto Y; Watanabe M
Eur Neurol; 2010; 64(5):258-64. PubMed ID: 20948218
[TBL] [Abstract][Full Text] [Related]
2. Early stroke treatment with IV t-PA associated with early recanalization.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Matsumoto N; Yamashita S
J Neurol Sci; 2010 Aug; 295(1-2):53-7. PubMed ID: 20570289
[TBL] [Abstract][Full Text] [Related]
3. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
4. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
5. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
6. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
Yalcin-Cakmakli G; Akpinar E; Topcuoglu MA; Dalkara T
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):74-7. PubMed ID: 19110150
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
9. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
11. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
[TBL] [Abstract][Full Text] [Related]
12. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
13. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
[TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy in cerebral infarction].
Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L
Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
16. Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization.
Sakamoto Y; Kimura K; Shibazaki K; Inoue T; Uemura J; Aoki J; Sakai K; Iguchi Y
Int J Stroke; 2013 Jul; 8(5):321-6. PubMed ID: 23013151
[TBL] [Abstract][Full Text] [Related]
17. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
18. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y
J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial thrombolysis and stent placement for acute basilar artery occlusion.
Yu YY; Niu L; Gao L; Zhao ZW; Deng JP; Qu YZ; Jiao DR; Yang JQ; Gao GD
J Vasc Interv Radiol; 2010 Sep; 21(9):1359-63. PubMed ID: 20688533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]